They’re not offering a comparison and simply saying those results were achieved after only being treated with Vaxinia. It’s possible the combo arm results could be even better.
Then consider the possibility of how well onCARlytics in combo with anti-CD19 would go treating residual tumours…
Early indications are looking very promising and the higher doses and/or combo treatment should have even better outcomes.
Ann: Imugene CF33 Oncolytic Virus Study to be Showcased at SITC, page-100
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
-0.006(8.82%) |
Mkt cap ! $455.6M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.2¢ | $3.774M | 58.30M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3402693 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 610000 | 3 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |